Analysis of Telix Pharmaceuticals, Bank of Queensland, MAAS Group Holdings
Fund Manager Chris Pedersen discusses Telix Pharmaceuticals, Bank of Queensland and MAAS Group Holdings.
Read More
Bank Of Queensland Limited
BOQ is one of Australia’s leading regional banks. We’re also among the few still not owned by one of the big banks.
At BOQ, most of our branches are run by local Owner-Managers. This means they’re running a small business and understand what it means to deliver personal service.
We pride ourselves on building long-term customer relationships that are based on mutual respect and understanding.
We have more than 180 branches across Australia and in each and every one of them you’ll find us really getting to know our customers and recognising the things they need. It’s how we’ve been doing business since 1874.
We’ve created simple, easy-to-understand banking products to help support our customers’ financial needs. We offer a range of these products and services to individuals, as well as businesses.
We’re one of the top 100 Australian companies ranked by market capitalisation on the Australian Securities Exchange and are regulated by the Australian Prudential Regulation Authority as an Authorised Deposit-taking Institution.
Spotlight Videos
Analysis of Telix Pharmaceuticals, Bank of Queensland, MAAS Group Holdings
Fund Manager Chris Pedersen discusses Telix Pharmaceuticals, Bank of Queensland and MAAS Group Holdings.
WATCH VIDEOAll Bank Of Queensland Limited Content
News
BoQ manages price uptick in the wake of report
Despite cutting its interim dividend and reporting a slump in earnings and surge in costs, shares in the Bank of Queensland (ASX:BOQ) still managed a solid 5.1% gain on the day in the wake of the release of its half-year report.
Read More
Bank of Queensland cuts interim dividend
Bank of Queensland (ASX:BOQ) has cut its interim dividend after reporting a sharp slide in revenue and cash earnings for the six months to February 29.
Read More
Bank of Queensland’s year: Challenges, earnings, and outlook
In the realm of profit announcements, cash earnings typically reign supreme for most banks, though Westpac has reverted to using statutory earnings.
Read More
Analyst Views
BOQ – Macquarie rates the stock as Neutral
Macquarie downgrades its rating for Bank of Queensland to Neutral from Outperform. The target price falls to $9 from $9.25.
Read More
BOQ – Morgans rates the stock as Add
The Add rating is unchanged and the target is increased to $10.50 from $10.
Read More
BOQ – Morgans rates the stock as Hold
Bank of Queensland's first half result missed the broker on slower revenues and higher expenses. As the broker had expected, following APRA's directive, the bank has deferred its interim dividend. On the expectation of increased loan impairments, the broker cuts FY earnings forecasts by -12%.
Read More
